Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Boston Scientific Corp (BSX)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Boston Scientific Corp.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 885725.
Total stock buying since 2015: $9,656,193.
Total stock sales since 2015: $529,079,619.
Total stock option exercises since 2015: $72,235,199.
Table 3. Detailed insider trading at Boston Scientific Corp (BSX) , Part 4
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2021-07-27 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 13,850 | 23.41 | 324,228 |
2021-07-27 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Sale | 728 | 45.00 | 32,760 |
2021-07-27 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Sale | 9,673 | 4,500.00 | 43,528,500 |
2021-07-27 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 4,250 | 13.08 | 55,590 |
2021-07-27 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 6,748 | 45.22 | 305,144 |
2021-07-27 | Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio) | Sale | 105,490 | 45.00 | 4,747,366 |
2021-07-27 | Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio) | Option Ex | 70,306 | 6.28 | 441,521 |
2021-07-23 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Sale | 11,348 | 44.00 | 499,312 |
2021-07-23 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 11,348 | 14.70 | 166,758 |
2021-07-15 | Carruthers Wendy (SVP, Human Resources) | Sale | 3,321 | 42.42 | 140,876 |
2021-07-06 | Mahoney Michael F (Chairman, President & CEO) | Sale | 201,041 | 43.41 | 8,726,586 |
2021-07-06 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 201,041 | 6.83 | 1,374,115 |
2021-07-01 | Olson Scott (SVP & Pres, Rhythm Management) | Sale | 700 | 42.78 | 29,946 |
2021-07-01 | Olson Scott (SVP & Pres, Rhythm Management) | Option Ex | 1,771 | .00 | 0 |
2021-07-01 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 855 | .00 | 0 |
2021-07-01 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 728 | .00 | 0 |
2021-06-24 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Sale | 16,450 | 44.03 | 724,293 |
2021-06-24 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 16,450 | 17.26 | 283,927 |
2021-06-16 | Monson Jonathan (VP, Global Controller and CAO) | Sale | 8,833 | 42.76 | 377,734 |
2021-06-03 | Pierce David A (EVP Pres MedSurg) | Sale | 1,654 | 41.36 | 68,409 |
2021-06-01 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,762 | .00 | 0 |
2021-06-01 | Mackey Edward F (EVP, Operations) | Sale | 68,173 | 42.71 | 2,911,600 |
2021-06-01 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,973 | .00 | 0 |
2021-05-28 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 78,192 | 42.59 | 3,330,431 |
2021-05-01 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 2,061 | .00 | 0 |
2021-04-30 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 3,572 | 43.51 | 155,399 |
2021-04-30 | Carruthers Wendy (SVP, Human Resources) | Sale | 13,750 | 43.72 | 601,191 |
2021-04-28 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 48,439 | 43.98 | 2,130,347 |
2021-04-28 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 48,439 | 7.39 | 357,964 |
2021-04-15 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Sale | 9,676 | 40.00 | 387,040 |
2021-04-15 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 4,250 | 13.08 | 55,590 |
2021-04-15 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 28,123 | 40.95 | 1,151,636 |
2021-04-15 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 28,123 | 6.28 | 176,612 |
2021-04-01 | Olson Scott (SVP & Pres, Rhythm Management) | Sale | 700 | 38.61 | 27,027 |
2021-03-16 | Pierce David A (EVP Pres MedSurg) | Sale | 7,603 | 39.36 | 299,246 |
2021-03-03 | Brennan Daniel J. (EVP and CFO) | Sale | 12,127 | 38.69 | 469,181 |
2021-03-03 | Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio) | Option Ex | 3,603 | .00 | 0 |
2021-03-02 | Brennan Daniel J. (EVP and CFO) | Sale | 9,475 | 38.84 | 368,037 |
2021-03-02 | Pierce David A (EVP Pres MedSurg) | Sale | 1,360 | 38.90 | 52,904 |
2021-02-28 | Olson Scott (SVP & Pres, Rhythm Management) | Option Ex | 1,426 | .00 | 0 |
2021-02-28 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,018 | .00 | 0 |
2021-02-28 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 815 | .00 | 0 |
2021-02-28 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 1,426 | .00 | 0 |
2021-02-28 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,018 | .00 | 0 |
2021-02-28 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,528 | .00 | 0 |
2021-02-28 | Mackey Edward F (EVP, Operations) | Option Ex | 2,444 | .00 | 0 |
2021-02-28 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,833 | .00 | 0 |
2021-02-28 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,222 | .00 | 0 |
2021-02-28 | Brennan Daniel J. (EVP and CFO) | Option Ex | 4,481 | .00 | 0 |
2021-02-28 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,037 | .00 | 0 |
2021-02-28 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,629 | .00 | 0 |
2021-02-28 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,330 | .00 | 0 |
2021-02-28 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,444 | .00 | 0 |
2021-02-28 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,629 | .00 | 0 |
2021-02-23 | Brennan Daniel J. (EVP and CFO) | Sale | 24,846 | 39.23 | 974,708 |
2021-02-23 | Brennan Daniel J. (EVP and CFO) | Option Ex | 24,846 | 7.16 | 177,897 |
2021-02-23 | Pierce David A (EVP Pres MedSurg) | Sale | 2,836 | 39.20 | 111,171 |
2021-02-22 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,159 | .00 | 0 |
2021-02-22 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 1,159 | .00 | 0 |
2021-02-22 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 1,738 | .00 | 0 |
2021-02-22 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,014 | .00 | 0 |
2021-02-22 | Mackey Edward F (EVP, Operations) | Option Ex | 2,897 | .00 | 0 |
2021-02-22 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 2,028 | .00 | 0 |
2021-02-22 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,594 | .00 | 0 |
2021-02-22 | Brennan Daniel J. (EVP and CFO) | Option Ex | 5,794 | .00 | 0 |
2021-02-22 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,318 | .00 | 0 |
2021-02-22 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 2,318 | .00 | 0 |
2021-02-22 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 23,175 | .00 | 0 |
2021-02-22 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,607 | .00 | 0 |
2021-02-22 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,883 | .00 | 0 |
2021-02-22 | Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio) | Option Ex | 4,056 | .00 | 0 |
2021-02-21 | Olson Scott (SVP & Pres, Rhythm Management) | Option Ex | 1,090 | .00 | 0 |
2021-02-21 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 779 | .00 | 0 |
2021-02-21 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 623 | .00 | 0 |
2021-02-21 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 934 | .00 | 0 |
2021-02-21 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Option Ex | 1,324 | .00 | 0 |
2021-02-21 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,012 | .00 | 0 |
2021-02-21 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,713 | .00 | 0 |
2021-02-21 | Mackey Edward F (EVP, Operations) | Option Ex | 2,726 | .00 | 0 |
2021-02-21 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,713 | .00 | 0 |
2021-02-21 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,090 | .00 | 0 |
2021-02-21 | Brennan Daniel J. (EVP and CFO) | Option Ex | 3,661 | .00 | 0 |
2021-02-21 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,804 | .00 | 0 |
2021-02-21 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,558 | .00 | 0 |
2021-02-21 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 16,824 | .00 | 0 |
2021-02-21 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,492 | .00 | 0 |
2021-02-21 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,713 | .00 | 0 |
2021-02-21 | Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio) | Option Ex | 3,894 | .00 | 0 |
2021-02-19 | Pierce David A (EVP Pres MedSurg) | Sale | 1,484 | 38.00 | 56,392 |
2021-02-18 | Olson Scott (SVP & Pres, Rhythm Management) | Option Ex | 1,037 | .00 | 0 |
2021-02-18 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,111 | .00 | 0 |
2021-02-18 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 637 | .00 | 0 |
2021-02-18 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 1,111 | .00 | 0 |
2021-02-18 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Option Ex | 1,704 | .00 | 0 |
2021-02-18 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,037 | .00 | 0 |
2021-02-18 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 2,371 | .00 | 0 |
2021-02-18 | Mackey Edward F (EVP, Operations) | Option Ex | 2,223 | .00 | 0 |
2021-02-18 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 2,001 | .00 | 0 |
2021-02-18 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,185 | .00 | 0 |
2021-02-18 | Brennan Daniel J. (EVP and CFO) | Option Ex | 3,706 | .00 | 0 |
2021-02-18 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,816 | .00 | 0 |
2021-02-18 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,853 | .00 | 0 |
2021-02-18 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 16,306 | .00 | 0 |
2021-02-18 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,668 | .00 | 0 |
2021-02-18 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,778 | .00 | 0 |
2021-02-18 | Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio) | Option Ex | 3,706 | .00 | 0 |
2021-02-17 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 32,353 | 7.47 | 241,676 |
2021-02-16 | Pierce David A (EVP Pres MedSurg) | Sale | 1,540 | 38.28 | 58,951 |
2021-02-15 | Olson Scott (SVP & Pres, Rhythm Management) | Option Ex | 1,292 | .00 | 0 |
2021-02-15 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,107 | .00 | 0 |
2021-02-15 | Monson Jonathan (VP, Global Controller and CAO) | Option Ex | 738 | .00 | 0 |
2021-02-15 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 923 | .00 | 0 |
2021-02-15 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Option Ex | 1,107 | .00 | 0 |
2021-02-15 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,107 | .00 | 0 |
2021-02-15 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,846 | .00 | 0 |
2021-02-15 | Mackey Edward F (EVP, Operations) | Option Ex | 2,768 | .00 | 0 |
2021-02-15 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,846 | .00 | 0 |
2021-02-15 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,200 | .00 | 0 |
2021-02-15 | Brennan Daniel J. (EVP and CFO) | Option Ex | 4,153 | .00 | 0 |
2021-02-15 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 2,030 | .00 | 0 |
2021-02-15 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,661 | .00 | 0 |
2021-02-15 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,457 | .00 | 0 |
2021-02-15 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,768 | .00 | 0 |
2021-02-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,661 | .00 | 0 |
2021-02-15 | Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio) | Option Ex | 4,614 | .00 | 0 |
2021-02-12 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Sale | 28,883 | 38.65 | 1,116,356 |
2021-02-12 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 5,494 | 38.75 | 212,892 |
2021-02-08 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Sale | 16,902 | 39.39 | 665,820 |
2021-02-08 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 9,000 | 13.08 | 117,720 |
2021-02-04 | Pierce David A (EVP Pres MedSurg) | Sale | 11,317 | 38.00 | 430,046 |
2021-02-01 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 3,130 | .00 | 0 |
2021-01-05 | Brennan Daniel J. (EVP and CFO) | Sale | 17,083 | 35.32 | 603,405 |
2021-01-05 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 8,108 | 35.31 | 286,334 |
2021-01-04 | Olson Scott (SVP & Pres, Rhythm Management) | Sale | 700 | 36.08 | 25,256 |
2021-01-01 | Eddy Jodi Euerle (SVP, Chief Info & Digital Off.) | Option Ex | 5,439 | .00 | 0 |
2021-01-01 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Option Ex | 6,527 | .00 | 0 |
2021-01-01 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 6,527 | .00 | 0 |
2021-01-01 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 10,879 | .00 | 0 |
2021-01-01 | Mackey Edward F (EVP, Operations) | Option Ex | 16,318 | .00 | 0 |
2021-01-01 | Thepaut Eric Francis Yves (EVP & Pres, Eur, Mid-East, Afr) | Option Ex | 10,879 | .00 | 0 |
2021-01-01 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 7,071 | .00 | 0 |
2021-01-01 | Brennan Daniel J. (EVP and CFO) | Option Ex | 24,479 | .00 | 0 |
2021-01-01 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 11,967 | .00 | 0 |
2021-01-01 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 9,791 | .00 | 0 |
2021-01-01 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 108,797 | .00 | 0 |
2021-01-01 | Pierce David A (EVP Pres MedSurg) | Option Ex | 16,318 | .00 | 0 |
2021-01-01 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 9,791 | .00 | 0 |
2021-01-01 | Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio) | Option Ex | 27,199 | .00 | 0 |
2020-12-03 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 649 | .00 | 0 |
2020-12-01 | Olson Scott (SVP & Pres, Rhythm Management) | Option Ex | 1,485 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BSX listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Boston Scientific Corp (symbol BSX,
CIK number 885725) see
the Securities and Exchange Commission (SEC) website.